ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael H Silverman, MD
Acurx Pharmaceuticals Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Acurx Site #118: Dr Janet Reiser
Scottsdale, Arizona, United States
- Acurx Site #115: Dr Neera Grover
Apple Valley, California, United States
- Acurx Site #125: Dr Karen Simon
Camarillo, California, United States
- Acurx Site #111: Dr Jatinder Pruthi
Lancaster, California, United States
- Acurx Site #131: Dr Michael Jardula
Palm Springs, California, United States
- Acurx Site #129: Dr Stuart Cohen
Sacramento, California, United States
- Acurx Site #105
Doral, Florida, United States
- Acurx Site #122: Dr Faride Ramos
Doral, Florida, United States
- Acurx Site #101: Dr Idalia Acosta
Miami, Florida, United States
- Acurx Site #108: Dr Idania Garcia del Sol
Miami, Florida, United States
- Acurx Site #116: Dr Erick Juarez
Miami, Florida, United States
- Acurx Site #119: Dr Jorge Paoli-Bruno
Miami, Florida, United States
- Acurx Site #124: Dr Yunior Silva-Barrero
Miami, Florida, United States
- Acurx Site #107: Dr Belkis Delgado
Miami Springs, Florida, United States
- Acurx Site #117: Dr Rafael Companioni
Panama City, Florida, United States
- Acurx Site #102: Dr Richard Nathan
Idaho Falls, Idaho, United States
- Acurx Site #123: Dr Harry Schrager
Newton, Massachusetts, United States
- Acurx Site #104: Dr Jeanmarie Houghton
Worcester, Massachusetts, United States
- Acurx Site #103: Dr John Pullman
Butte, Montana, United States
- Acurx Site #130: Dr Michael Digiovanna
North Massapequa, New York, United States
- Acurx Site #127: Dr Christopher Connolley
Winston-Salem, North Carolina, United States
- Acurx Site #126: Dr Andrew Pearson
Myrtle Beach, South Carolina, United States
- Acurx Site #114: Dr Eugene Ryan
Chattanooga, Tennessee, United States
- Acurx Site #121: Dr Ramesh Gowrappala
Houston, Texas, United States
- Acurx Site #120: Dr Vanna Gold
Lampasas, Texas, United States
- Acurx Site #113: Dr Jennifer Vincent
Temple, Texas, United States
- Acurx Site #110: Dr Val Hansen
Bountiful, Utah, United States
- Acurx Site #106: Dr Bezawit Tekola
Fairfax, Virginia, United States
- Acurx Site #109: Dr Robert Brennan
Lynchburg, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Mar 2020
- Primary completion
- 3 Oct 2023
- Completion
- 15 Nov 2023
- Last update posted
- 17 Jan 2025
- Registered enrollment
- 53
- Registry id
- NCT04247542
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.